Lux Capital

Founded in 2000, Lux Capital is a venture capital firm based in New York and Silicon Valley. It manages over $5 billion in assets, focusing on seed to growth investments at the intersection of technology and sciences. Lux actively supports entrepreneurs building successful businesses in high-growth sectors such as biochemistry, material science, electronics, infrastructure, aerospace, genomics, synthetic biology, and robotics.

Shahin Farshchi

General Partner

Peter Hebert

Managing Partner

Lan Jiang

Associate

Alex Nguyen

Partner

Ian Peikon

Venture Partner

Brandon Reeves

General Partner

Segolene Scarborough

CFO

Zack Schildhorn

Venture Partner

Deena Shakir

General Partner

Shaquille Vayda

Principal

Shaq Vayda

Principal

Josh Wolfe

Managing Partner

David Yang

Investor

Bilal Zuberi

General Partner

Tess Van Stekelenburg

Partner

Past deals in Early Venture Stage

Jericho Security

Series A in 2025
Jericho Security is a cybersecurity company specializing in protecting businesses from generative AI-based threats. It has developed a proprietary generative AI platform, cyberGPT, which simulates realistic cyberattacks, creates new defense strategies, and provides personalized training to enhance cybersecurity efficiency and prevent potential losses.

ConductorAI

Series A in 2025
ConductorAI specializes in AI-driven compliance solutions for government agencies. Its platform attributes work to relevant policies and procedures, connects model outputs with primary source materials, and surfaces existing policies within workflows, helping agencies navigate complex processes and ensure compliance.

tldraw

Series A in 2025
Founded in 2021, tldraw is a software company specializing in collaborative canvas solutions. Its flagship product, tldraw.com, offers an infinite canvas for whiteboarding and diagramming without requiring user login. The company also develops AI-integrated apps like Make Real and Teach.

Kela Technologies

Series A in 2025
Kela Technologies specializes in providing a secure, open platform that facilitates the swift and seamless integration of commercial and military systems, catering to the needs of Western defense. This platform offers battle-tested technology, interoperability, and adaptability, empowering defense organizations to tackle contemporary warfare challenges and keep pace with emerging innovations.

Atrandi Biosciences

Series A in 2025
Atrandi Biosciences is a biotechnology company focusing on next-generation single-cell technology, specifically single-cell eukaryotic DNA sequencing. This innovative approach enables the analysis of genomic alterations and cellular heterogeneity.

Physical Intelligence

Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

11x

Series A in 2024
11x develops autonomous digital workers to optimize organizational processes, with a focus on go-to-market operations. The company automates specific roles to reduce hiring costs and increase efficiency in sales and customer engagement. It offers an autonomous AI-driven workforce management platform that supports multilingual operations and aims to accelerate growth without adding headcount. Key products include Alice, an AI-powered sales development representative, and Jordan, another digital worker designed to handle routine tasks, enabling go-to-market teams to improve productivity and responsiveness.

Maven AGI

Series A in 2024
Maven AGI is a technology company specializing in modern artificial intelligence solutions. It focuses on revolutionizing customer support experiences by employing AI to reduce costs, enhance speed and quality, and boost operational efficiency. The company's AI solutions empower teams to increase productivity and focus on tasks that require human expertise. Additionally, Maven AGI offers services such as customer acquisition strategy and operational planning. With a team of 50 employees across various roles, the company aims to transform customer support through AI-driven insights and automation.

Privateer

Series A in 2024
Privateer develops an AI-powered data intelligence platform that transforms multi-domain information into actionable insights. It specializes in real-time satellite integration, AI-driven data fusion, and cross-domain analytics, empowering defense, civil, and commercial organizations to monitor global activity, anticipate risks, and make informed decisions.

Xaira Therapeutics

Venture Round in 2024
Xaira Therapeutics is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. Headquartered in the San Francisco Bay Area, Xaira brings together machine learning experts, expansive data generation, and robust therapeutic product development to advance treatments for various diseases.

Summer Health

Series A in 2024
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.

Nominal

Series A in 2024
Nominal develops a data infrastructure platform that empowers engineering teams across industries like aerospace, defense, automotive, and industrials to efficiently test and validate complex hardware systems. The platform offers multi-modal data ingestion, edge analytics, visualization, and automated validation capabilities.

Formic Technologies

Venture Round in 2024
Formic Technologies aims to boost humanity's collective output by making robotic automation accessible. It offers customized robots for operational automation in industries like food and beverage, manufacturing, and consumer packaged goods. Formic enables businesses to scale production quickly with minimal risk.

Together AI

Series A in 2024
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.

Armada

Series A in 2023
Armada develops an edge computing platform that connects individuals and businesses for real-time data processing and decision-making. It aims to bridge the digital divide by offering secure, scalable infrastructure alongside compatible software components.

Modal Labs

Series A in 2023
Modal Labs develops machine learning software that enables users to run code in the cloud. Its platform allows for the execution of machine learning models, parallel compute jobs, task queues, web apps, and more. It automates the launch of custom containers and runs scripts faster than on local machines, allowing data science teams to focus on their models without managing infrastructure.

Kinetic Automation

Series A in 2023
Kinetic specializes in modernizing automotive infrastructure to accommodate electric and autonomous vehicles. It employs hardware, robotics, software, and AI to deliver swift, accurate, and predictable maintenance services.

Mendaera

Series A in 2023
Mendaera is a medtech startup specializing in advanced healthcare technologies, focusing on robotics and diagnostic tools. Its platform integrates robotics, AI, real-time imaging, and connectivity to enable consistent medical interventions at scale, aiming to make high-quality care accessible to all patients.

Impulse Space

Series A in 2023
Impulse Space is an in-space transportation company founded by Tom Mueller, specializing in providing access beyond Low Earth Orbit (LEO) through a fleet of innovative transportation vehicles. The company’s flight-proven Mira vehicle employs a non-toxic, high-impulse chemical propulsion system, facilitating services such as orbital transport, constellation deployment, and precision reentry from LEO to Geostationary Orbit (GEO). Additionally, the high-energy Helios vehicle, powered by the Deneb engine, enables deliveries to a range of orbits including Medium Earth Orbit (MEO), GEO, heliocentric, lunar, and other planetary destinations. Impulse Space is committed to offering economical and efficient in-space transportation solutions, leveraging a team with a history of delivering reliable rockets to ensure rapid and dependable service for its customers.

Aera Therapeutics

Series A in 2023
Aera Therapeutics is a biotechnology company focused on advancing genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins derived from retroelements, which self-assemble into capsid-like structures capable of packaging and transferring nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to enhance the efficacy and reach of genetic therapies across various tissues and disease areas. Additionally, the company holds a licensed technology that features a therapeutic enzyme platform based on novel, compact, and programmable gene-editing enzymes, further expanding its capabilities in the field of genetic medicine.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Osmo

Venture Round in 2023
Osmo is a technology company that equips computers with the ability to sense smell using advanced AI and olfactory science. Initially focused on enhancing fragrance products, Osmo's long-term goal is to improve human health and well-being through innovative applications of smell detection.

Cajal Neuroscience

Series A in 2022
Cajal Neuroscience is a biotechnology company dedicated to discovering novel targets and therapeutics for neurodegeneration. It integrates human genetics, functional genomics, and advanced microscopy to accelerate drug discovery in this field.

Impulse

Series A in 2022
Impulse is a manufacturer of innovative electric home appliances aimed at transforming the home appliance sector by reducing reliance on natural gas and minimizing carbon emissions. The company focuses on integrating battery technology into its products, allowing for energy storage without the need for extensive upgrades to electrical panels. Their flagship product is a high-performance induction stove equipped with a built-in battery, which enables users to electrify their homes with minimal rewiring. This approach not only enhances appliance performance but also facilitates the addition of energy storage to the grid, promoting a healthier and more sustainable living environment for both residential and commercial users.

Column

Series A in 2022
Column develops technology to enhance public information systems. It offers a user-friendly platform for publishers to manage and deliver legal notices efficiently, serving governments, legal services, individuals, and businesses.

Epsilon3

Series A in 2022
Epsilon3 develops software for spacecraft operations, aiming to modernize space missions by providing an industry-standard platform for operational procedures and complex engineering tasks. The platform supports interactive, real-time synchronized procedures across multiple programs and missions and includes analytics, reports, and dashboards for visibility and decision making. It serves satellite operators, space manufacturers, and integrators, helping them save time and money and improve lifecycle efficiency from planning through execution and validation.

Anagenex

Series A in 2022
Anagenex is a biotechnology company developing a novel platform for drug discovery. This platform focuses on challenging targets by combining machine learning with DNA-encoded libraries and proprietary AI models to accelerate small molecule drug discovery.

Fruitful

Series A in 2022
Fruitful is a financial membership platform designed to help Americans understand, organize, and optimize their finances. It offers one-on-one financial guidance tailored to members' unique lifestyles and goals, along with stress-free saving, spending, and investing features. Fruitful partners members with supportive Certified Financial Plannersâ„¢ who provide ongoing advice and investment strategies at a fraction of the cost of traditional advisory firms.

LatchBio

Series A in 2022
LatchBio is a biotechnology company founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman. It focuses on developing a data infrastructure aimed at supporting the open-source biocomputing revolution. The company provides a bioinformatics platform specifically designed for cell and gene therapy startups, offering a modern cloud computing stack that enables biotech labs to manage and execute custom workflows, pipelines, and machine learning models. This platform allows scientists to create bioinformatic queries efficiently, without requiring command-line expertise or the burdens of complex system setups. By streamlining data integration and computational processes, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.

Umba

Series A in 2022
Umba is an African digital bank offering free bank accounts and connected financial services. Founded in 2017, it operates in Kenya and Nigeria, providing customers with complete control of their finances via a single mobile application.

Hadrian

Series A in 2022
Hadrian is a machine parts startup that manufactures precision components for technology companies, including aerospace and defense programs. It builds autonomous, software-defined precision component factories and an autonomous manufacturing platform that integrates software, robotics, and full-stack capabilities to scale mission-critical programs across space, aviation, and maritime sectors. By enabling aerospace startups, suppliers, and defense contractors to produce essential components with lower costs and greater efficiency, Hadrian aims to accelerate development timelines and reduce manufacturing complexity.

Cloaked

Series A in 2022
Cloaked is a consumer-focused privacy company that empowers individuals to manage their personal data securely. Its platform generates unlimited, unique identities, allowing users to access online services without revealing sensitive information such as emails, phone numbers, or addresses.

Alife Health

Series A in 2022
Alife Health develops artificial intelligence tools for fertility care to improve pregnancy outcomes. The company provides AI-based health technology that helps doctors select the healthiest embryos and supports IVF planning, aiming to increase the likelihood of healthy pregnancies. It connects fertility specialists with patients to streamline IVF treatment and decision making. Founded in 2020 and headquartered in San Francisco, California, the company focuses on applying deep learning and software to reproductive medicine, enabling clinicians to personalize embryo selection and patient care. Alife Health strives to enhance access to effective fertility treatments and assist prospective parents in achieving successful pregnancies.

Creyon Bio

Series A in 2022
Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.

Neo.tax

Series A in 2022
Neo.tax develops tax automation software for filing and optimizing tax credits. Based in Mountain View, California, the company builds tools that automate data collection from emails, documents, project management tools, and financial systems, and generate reports detailing activities, expenses, and methodologies used to claim tax credits such as the R&D tax credit. The platform aims to improve accuracy and speed in the tax filing process, helping finance teams at startups to larger companies understand evolving tax rules, including changes to R&D capitalization, and to optimize their tax liability. By combining machine learning and integrated data sources, Neo.tax seeks to provide audit-ready documentation and reduce manual effort in tax preparation.

Parallel Markets

Series A in 2022
Founded in 2018, Parallel Markets operates an online platform that streamlines investor verification and accreditation for financial platforms. It enables investors to share their credentials across platforms with a single click, simplifying onboarding processes for both individuals and entities while ensuring regulatory compliance.

Gandeeva Therapeutics

Series A in 2022
Gandeeva Therapeutics is a precision biotechnology company that combines cryogenic electron microscopy (cryo-EM) and machine learning to discover and develop therapeutics by targeting and modulating key protein-protein interactions. Its structure-guided drug discovery platform comprises SPOTLIGHT for target prediction and validation, HYPERFOCUS for hit identification from virtual and fragment libraries, and CRYO-CADD for lead optimization. The company pursues a preclinical oncology program focused on difficult-to-treat cancers with novel protein interaction modulators, including interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area of Canada, Gandeeva aims to advance differentiated therapeutics and improve outcomes for patients by leveraging its integrated imaging, modeling, and screening capabilities.

Formic Technologies

Series A in 2022
Formic Technologies aims to boost humanity's collective output by making robotic automation accessible. It offers customized robots for operational automation in industries like food and beverage, manufacturing, and consumer packaged goods. Formic enables businesses to scale production quickly with minimal risk.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Waymark

Series A in 2022
Waymark is a healthcare company focused on improving access to and quality of care for Medicaid beneficiaries. It delivers community-based services and collaborates with primary care providers to enhance access and health outcomes for patients enrolled in Medicaid. The company provides health plans, insulin education, and training, and creates employment opportunities for community-based care teams, supporting coordinated care and patient engagement so beneficiaries can monitor and manage their health.

Perchwell

Series A in 2021
Perchwell is a data and workflow platform for the residential real estate industry. It provides real-time market analysis and insights, listing data management and syndication, scheduling of property viewings, and tools for client collaboration, helping brokers and agents make informed decisions and offer timely guidance to clients.

Nomic

Series A in 2021
Nomic is a bioengineering company developing the nELISA platform for measuring proteins at scale and high throughput. They offer protein profiling solutions empowering scientists to decide experiment scope and scale.

Shiru

Series A in 2021
Shiru, Inc. is a food technology company based in Oakland, California, established in 2019. It specializes in the development and production of proteins aimed at replacing dairy products and eggs within the food industry. Utilizing artificial intelligence, bioinformatics, and precision biology, Shiru focuses on the discovery and creation of novel, sustainable protein ingredients. By leveraging computational design, the company aims to provide enhanced protein solutions that support environmentally friendly practices while meeting consumer demands. Shiru's innovative approach positions it at the forefront of efforts to create sustainable and healthier food options.

Copia Automation

Series A in 2021
Copia Automation is a technology company that specializes in providing modern developer tools tailored for industrial automation engineers. Their primary product offers Git-based source control for Programmable Logic Controller (PLC) programming, enhancing version control, change visibility, and collaboration. This streamlines machinery commissioning and operation, leading to faster delivery times and maximized uptime for clients across various industries.

Kingdom Supercultures

Series A in 2021
Kingdom Supercultures is a Brooklyn-based company established in 2019 that specializes in developing and producing microbial cultures for the food industry. The company focuses on reassembling nature's microbes into innovative combinations, allowing food manufacturers to create new varieties of food with enhanced benefits. Their product line includes Koji, a traditional Japanese ingredient used in miso, sake, and soy sauce, as well as microbial cultures for fermented sodas, beers, and plant-based dairy alternatives. Kingdom Supercultures employs an automated scientific platform that features a comprehensive biobank of Generally Recognized As Safe (GRAS) microbial strains and utilizes advanced algorithms to predict and assemble microbial communities. By providing functional ingredients and biopreservatives, the company aims to support healthy and sustainable food development across various industries, including food, beverage, personal care, and beauty.

A-Alpha Bio

Series A in 2021
A-Alpha Bio, Inc. is a biotechnology company specializing in synthetic biology and advanced quantitative measurement of protein interactions to facilitate drug development. Founded in 2017 and headquartered in Seattle, Washington, the company offers its proprietary AlphaSeq platform, which enables high-throughput mapping of protein-protein interactions. This technology allows for the simultaneous identification and quantification of interactions among thousands of protein pairs, streamlining the drug discovery process by aiding in the identification of potential drug targets and enhancing the understanding of disease mechanisms. By providing biologics and molecular glue discovery and optimization services, A-Alpha Bio supports pharmaceutical companies in optimizing binding and specificity to multiple target proteins. The team comprises synthetic biologists, structural biologists, and next-generation sequencing experts dedicated to overcoming challenges in the drug development process.

Atavistik Bio

Series A in 2021
Atavistik Bio is a pre-clinical biotechnology company dedicated to discovering and developing novel therapies for metabolic diseases and cancer. The company specializes in identifying metabolite-protein interactions and leveraging nature's allosteric control mechanisms to create innovative drug candidates. By focusing on genetically validated targets, Atavistik Bio aims to pioneer first-in-class treatments that harness these unique biological processes, positioning itself at the forefront of biopharmaceutical advancements.

Ahana

Series A in 2021
Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions using PrestoDB. The company aims to make interactive analytics more accessible by simplifying the process for organizations of various sizes. Ahana also works to promote growth within the Presto community, building on its widespread use at large internet companies like Facebook, Uber, and Twitter.

HiHello

Series A in 2021
HiHello designs and develops a software solution for managing professional contacts. Its application enables users to share their contact details securely with clients and friends via unique codes or messages. Incorporated in 2018, HiHello is based in Palo Alto, California.

Varda

Series A in 2021
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Enveda Biosciences

Series A in 2021
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.

System

Series A in 2021
System develops an artificial intelligence powered platform to model the world as an interconnected system. The platform offers a quantitative system graph that extracts insights from verified sources, enabling researchers, policymakers, and healthcare professionals to analyze complex challenges and make data-driven decisions.

Dyno Therapeutics

Series A in 2021
Founded in 2018, Dyno Therapeutics specializes in developing adeno-associated virus (AAV) vectors for in vivo gene therapy delivery. The company's proprietary platform combines DNA synthesis of AAV capsids with sequencing and machine learning to create novel vectors tailored for safe, efficient, and targeted therapeutic solutions.

Eikon Therapeutics

Series A in 2021
Eikon Therapeutics is a biopharmaceutical company that uses proprietary live-cell imaging platforms to discover and develop therapeutics for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company applies super-resolution, single-molecule, and real-time molecular-resolution observations to study how compounds interact with individual proteins in living cells. By integrating biology, engineering, and chemistry, Eikon seeks to identify previously intractable targets, accelerate the drug-discovery process, and expand its clinical pipeline through platforms that reveal target biology and compound-protein interactions in their native cellular context.

Pawp

Series A in 2021
Pawp, Inc. is a digital health clinic and telehealth platform founded in 2020 and based in New York, New York. The company focuses on providing pet owners with 24/7 access to licensed veterinary professionals, enabling them to manage their pets' health effectively. Pawp's services aim to reduce unnecessary veterinary visits by offering expert consultations online, thereby lowering costs for pet owners. Additionally, the company provides a pet emergency fund of $3,000 per year, acting as a financial safety net for unforeseen veterinary expenses. By combining access to veterinary care and emergency funding, Pawp empowers pet owners to make informed health decisions for their pets.

Higharc

Series A in 2021
Higharc, Inc. is a technology company based in Durham, North Carolina, founded in 2018. It offers a comprehensive web platform designed for homebuilders and new homebuyers, focusing on three-dimensional home design and customization. The platform allows users to create tailored home designs while managing plans, standards, and options within a single interface. It provides accurate materials lists and generates permit-ready construction documents, streamlining the building process. By enabling builders to design and sell homes in 3D, Higharc aims to enhance the efficiency of design, construction, and sales, ultimately reducing material waste and costly errors. The company's mission is to support builders in creating high-quality homes and communities in a more affordable manner.

Buf Technologies

Series A in 2021
Buf Technologies develops tools to simplify the lifecycle of Protocol Buffers APIs. Its product suite includes a linter that enforces API design best practices, a breaking-change detector that checks compatibility at the source or wire level, and a configurable file builder that generates images. The company helps teams create, lint, and distribute consistent APIs, protect against incompatible schema changes during evolution, and manage protocols across an organization so development remains focused on core work. Based in Buffalo, New York, Buf supports teams in standardizing API design and ensuring cross-team compatibility throughout the API lifecycle.

Multiply Labs

Series A in 2021
Multiply Labs develops robotic-enabled manufacturing for personalized pharmaceutical capsules, combining pharmaceutical science with robotics to produce tailor-made capsules that align with individual patient metabolic needs. The company operates a robotic manufacturing facility and has introduced 3D-printed capsules, aiming to address scaling challenges in biotech and improve the efficiency and cost of producing patient-specific medicines.

ZEDEDA

Series A in 2021
ZEDEDA, Inc. is a developer of cloud-native edge virtualization software that provides visibility, control, and security for IoT edge gateways, applications, and networks at the enterprise edge. Founded in 2016 and headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, India, the company offers solutions such as Edge Quick Connect for Azure IoT Edge. This software-as-a-service enables customers to manage and secure their IoT deployments through virtualization and facilitates the use of cloud-managed gateways for remote administration. ZEDEDA's platform supports a variety of applications, including predictive analytics in renewable energy and industrial automation, allowing organizations to monitor and manage real-time edge applications while avoiding vendor lock-in.

Plexium

Series A in 2021
Plexium, Inc. is a biotechnology company based in San Diego, California, specializing in the development of targeted protein degradation therapeutics aimed at treating cancer and neurodegenerative diseases. Founded in 2017, Plexium focuses on identifying E3 ligase modulating small molecules to create innovative therapies. The company has developed a screening platform known as DELPhe, which utilizes advanced techniques to miniaturize cell-based assays for high-content readouts. This platform enables the modulation of E3 ligases to selectively target various cancers, including small cell lung and breast tumors, while also inducing immune responses. By exploring next-generation drug candidates that extend beyond traditional approaches, Plexium is poised to uncover new therapeutic possibilities across a wide range of medical applications.

Vosbor

Series A in 2021
Founded in 2019, Vosbor is a global digital marketplace for bulk agricultural commodities trading. It connects buyers and sellers, facilitating transparent and secure transactions of corn, wheat, soybeans, palm oil, and other commodities.

Runway

Series A in 2020
Runway, established in 2018, specializes in applied AI research and development. It offers an innovative video editing platform for professionals, utilizing AI-powered tools that enable intuitive manipulation and creation of visual content through text-based commands.

LabGenius

Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Auransa

Series A in 2020
Auransa Inc. is a clinical stage drug development company founded in 2014 and based in Palo Alto, California. The company focuses on inventing novel drugs for challenging diseases, including cancer, autoimmune disorders, and neurological conditions, utilizing its proprietary AI-driven drug discovery platform. This platform enables Auransa to analyze extensive genomics data from human disease tissues, facilitating the study of molecular disease subtypes and the prediction of effective compounds and targets for specific patient populations. Auransa's current pipeline includes a first-in-class investigational new drug for cancer that is undergoing clinical trials. Additionally, the company collaborates with various partners in the biopharma industry to enhance its research and development efforts.

Statespace

Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

Mos

Series A in 2020
Mos is a financial services company that provides student-focused financial solutions, including checking accounts, debit cards, and access to financial aid advisors. Its platform helps students simplify the financial aid process, identify scholarship opportunities, and access a broad range of financial sources to fund their education. By guiding users through costs, discounts, and payment options, Mos aims to remove financial barriers and expand opportunities for students. The company combines budgeting tools with expert support to help students manage funds, reduce fees, and secure additional financial assistance throughout the college journey. Through its mission to make higher education more accessible, Mos focuses on empowering students to navigate financing with clarity and confidence.

Braid Health

Series A in 2020
Braid Health, Inc. is a digital health innovation company founded in 2018 and based in San Francisco, California. It specializes in developing artificial intelligence-driven diagnostic tools specifically for radiology. By creating an AI-powered diagnostic collaboration platform, Braid Health enhances the speed, quality, and workflow of radiologists and healthcare providers. The company’s systems integrate AI diagnostics with the expertise of board-certified radiologists, facilitating real-time quality assurance and seamless Electronic Health Records (EHR) integration. This approach enables healthcare professionals to deliver accurate diagnoses efficiently, ultimately improving the quality of patient care.

Tecton

Series A in 2020
Tecton offers an enterprise-grade feature store, empowering businesses to harness machine learning effectively. Its platform addresses unique ML data requirements, enabling teams to build, serve, and scale features swiftly and reliably.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

AllStripes

Series A in 2020
AllStripes is a healthcare technology company focused on accelerating the development of new treatments for rare diseases. The company has created a platform that enables the generation of regulatory-ready evidence, facilitating rare disease research and drug development. AllStripes operates a two-sided network that connects patients with rare diseases and advocacy groups to life science companies seeking new drug candidates. Through this network, patients can contribute their medical data and participate in treatment research online, while life science companies gain access to valuable data and insights to support their drug development efforts.

Looking Glass Factory

Series A in 2020
Founded in 2015, Looking Glass Factory develops and manufactures holographic displays designed for 3D creators. Its flagship product, the Looking Glass, combines light field and volumetric display technologies to enable users to create, share, and interact with 3D content without needing VR or AR headsets.

Avail Medsystems

Series A in 2020
Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

Rivet

Series A in 2020
Rivet Health, Inc. is a company specializing in healthcare revenue cycle management through its software-as-a-service platform. Founded in 2018 and based in Cottonwood Heights, Utah, Rivet provides tools that enhance financial transparency and operational efficiency for healthcare providers and patients. Its offerings include features that allow providers to quote and collect patient costs upfront and manage payer contracts effectively. The software also helps patients understand their financial responsibilities, detect underpayments, and create accurate estimates, thereby fostering better communication between providers and payers. By addressing the complexities of healthcare transactions, Rivet aims to improve the overall experience for both patients and providers.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

SkySelect

Series A in 2020
SkySelect streamlines aircraft maintenance by offering an automated procurement platform for high-quality parts. It connects leading airlines with global suppliers, enhancing operational efficiency and on-time performance.

Lumafield

Series A in 2020
Lumafield provides industrial computed tomography solutions for non-destructive testing and inspection in engineering environments. Its Neptune X-ray CT scanner enables detailed imaging to analyze internal structures and detect defects across materials. The Voyager software platform delivers cloud-based AI-powered analysis, automated inspections, and collaboration tools to support product development from design through manufacturing. Triton is a high-speed CT system designed for rapid scanning in high-volume manufacturing settings. The company serves industries including aerospace, automotive, electronics, and medical devices, helping to improve product quality and reliability through advanced imaging and analysis capabilities.

Hugging Face

Series A in 2019
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.

Chronosphere

Series A in 2019
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Fiddler AI

Venture Round in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.

LabGenius

Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Variant Bio

Series A in 2019
Variant Bio Inc. is a biotechnology company focused on developing therapeutics through the exploration of human genetic diversity. Founded in 2018 and headquartered in Seattle, Washington, the company seeks to identify individuals and populations exhibiting extreme outlier traits relevant to various medical conditions. By employing advanced sequencing technologies, statistical genetics, and machine learning, Variant Bio analyzes the genetic underpinnings of these traits to uncover new therapeutic targets. The company's mission is to enhance global health by addressing unmet medical needs, particularly in areas such as neurodegenerative, autoimmune, and cardiometabolic diseases.

Fiddler AI

Series A in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.

Caper

Series A in 2019
Caper, founded in 2019, specializes in developing AI-powered smart shopping carts designed to revolutionize physical retail. Their technology, inspired by Amazon Go's innovations, integrates image recognition, sensor fusion, and artificial intelligence into a compact, user-friendly cart. Shoppers can simply place their groceries inside the cart for automatic scanning and checkout, eliminating the need for cashiers and enhancing shopping efficiency. Caper aims to rapidly scale its solution across existing grocery stores, aiming to transform traditional retail practices.

OpenSpace

Series A in 2019
OpenSpace develops automated 360-degree video capture and mapping for construction sites, providing photo documentation software that captures images frequently and ties them to project plans. Founded in 2017 and headquartered in San Francisco, OpenSpace offers reality capture and AI-powered analytics that create navigable, complete photo representations of job sites, enabling faster data capture from preconstruction through operations, improving collaboration and reducing risk compared with traditional text-based workflows.

Yonder

Series A in 2019
Yonder LLC, founded in 2017 and based in Austin, Texas, develops an application designed to help brands contextualize online information. The company aims to define the authentic internet category by providing cultural context to information as it circulates online. Yonder believes that adding this context is essential to prevent the dehumanization of information, which can contribute to issues such as fake accounts, misinformation, and disinformation. By striving to enhance the flow of information, Yonder seeks to foster a more trustworthy and open digital environment, countering trends of information gatekeeping and mistrust.

Lightform

Series A in 2019
Lightform, Inc. is a computer vision and hardware company based in San Francisco, California, founded in 2014. The company specializes in developing technology for projected augmented reality, offering sound-reactive projectors, projector kits, and creator products that transform spaces through projection mapping. Lightform's innovative hardware tools and desktop application enable users to create animated content for various scenes, control projectors wirelessly from laptops or phones, and seamlessly integrate real objects with projected light. The company also provides 3D scanning options that allow for the scanning of complex scenes, automatically fine-tuning alignment and enhancing the projection mapping workflow with AI-generated effects and filters.

Veo Robotics

Series A in 2019
Founded in 2016, Veo Robotics specializes in developing advanced robotics systems for manufacturing. Its flagship product enables industrial robots to collaborate safely with humans, enhancing flexibility, productivity, and efficiency in workcells.

ZEDEDA

Series A in 2019
ZEDEDA, Inc. is a developer of cloud-native edge virtualization software that provides visibility, control, and security for IoT edge gateways, applications, and networks at the enterprise edge. Founded in 2016 and headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, India, the company offers solutions such as Edge Quick Connect for Azure IoT Edge. This software-as-a-service enables customers to manage and secure their IoT deployments through virtualization and facilitates the use of cloud-managed gateways for remote administration. ZEDEDA's platform supports a variety of applications, including predictive analytics in renewable energy and industrial automation, allowing organizations to monitor and manage real-time edge applications while avoiding vendor lock-in.

Workit Health

Series A in 2019
Workit Health provides online therapeutic content and professional counseling services for substance use recovery. It offers Workit, an interactive platform for individuals seeking to reduce or quit alcohol consumption, providing discreet access to on-demand medical and psychosocial support.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Bright Machines

Series A in 2018
Bright Machines, Inc. is a manufacturing company that specializes in robotic arms and cells for micro factories, focusing on the assembly and inspection of products. Founded in 2018 and headquartered in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico, the company combines robotics and advanced software to enhance manufacturing processes. Its software-defined manufacturing platform utilizes artificial intelligence and machine learning to create adaptable, sensor-rich robots with computer vision capabilities. This innovative approach aims to reduce reliance on manual labor and help businesses meet the increasing demands of modern manufacturing, ultimately improving yields while lowering costs.

Aeva Technologies

Series A in 2018
Aeva Technologies develops sensing and perception technologies for autonomous systems by integrating vision, depth, and motion sensing into a single platform. Its core Frequency Modulated Continuous Wave (FMCW) LiDAR on chip enables 4D LiDAR with longer range, higher resolution, and the ability to measure velocity for every pixel, delivering robust performance in varying weather conditions. The company targets automated driving and applications across consumer electronics, health, industrial automation, and security. Founded in 2016 and based in California, Aeva operates globally.

Applied Intuition

Series A in 2018
Applied Intuition develops software infrastructure to safely develop, test, and deploy autonomous vehicles at scale. Founded in 2017 and based in Sunnyvale, California, it maintains offices in Silicon Valley and Detroit. The company offers an autonomous vehicle platform for simulation, validation, and deployment of advanced driver-assistance and automated driving systems, integrating AI-powered development tools with modular software architecture to help automotive manufacturers and mobility companies optimize autonomous system performance and streamline integration across diverse vehicle types and operating environments.

Yonder

Series A in 2018
Yonder LLC, founded in 2017 and based in Austin, Texas, develops an application designed to help brands contextualize online information. The company aims to define the authentic internet category by providing cultural context to information as it circulates online. Yonder believes that adding this context is essential to prevent the dehumanization of information, which can contribute to issues such as fake accounts, misinformation, and disinformation. By striving to enhance the flow of information, Yonder seeks to foster a more trustworthy and open digital environment, countering trends of information gatekeeping and mistrust.

Oasis Labs

Series A in 2018
Oasis Labs, Inc. is a blockchain technology company founded in 2018 and headquartered in San Francisco, California. It operates a privacy-first cloud computing platform designed for scalable and privacy-preserving smart contracts. The platform enables the development of decentralized applications that prioritize privacy and performance, addressing challenges related to data security and scalability in real-world applications. Oasis Labs offers a suite of tools, including privacy tools, development SDKs, and dashboards, that facilitate the creation and management of smart contracts while ensuring secure data handling across businesses. The company's innovative approach aims to enhance blockchain adoption by overcoming traditional limitations associated with performance and privacy.

Novel Effect

Series A in 2018
Novel Effect is a Seattle-based company specializing in voice-driven media and entertainment. It has developed an interactive storytelling application that utilizes voice recognition technology to synchronize theme music and sound effects with the reading experience. This innovative application provides voice-activated audio enhancements for children's books, allowing sound effects and music to play in real-time as a child reads. By blending the physical and digital worlds, Novel Effect creates immersive and engaging experiences that foster learning and interaction between children and parents, while ensuring that the content remains accessible and non-distracting.

Arraiy

Series A in 2018
Arraiy, Inc. is a technology company based in Palo Alto, California, that specializes in developing a computer vision and machine learning platform tailored for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy aims to transform the filmmaking process by collaborating with major studios and award-winning artists. The company's platform leverages advanced AI techniques to enhance visual storytelling, allowing creators to seamlessly integrate real and virtual worlds. By focusing on machine learning, Arraiy seeks to expand the creative possibilities for filmmakers, thereby unlocking a new era of visual storytelling. As of 2020, Arraiy operates as a subsidiary of Matterport, Inc.

Senti Biosciences

Series A in 2018
Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Pager

Series A in 2018
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Primer Technologies

Series A in 2017
Primer Technologies develops software that uses machine learning and natural language processing to parse, collate, and analyze large multilingual document sets. Its platform reads documents, discovers insights, and automatically generates reports comparable to those produced by human analysts. The technology helps governments and corporations monitor and understand a wide range of information across languages, translating vast text data into actionable intelligence. Founded in 2014, Primer Technologies is based in San Francisco. The solution automates the analysis of substantial text datasets, enabling organizations to extract meaning from extensive stores of text data and accelerate investigations and decision-making.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.